Overview
Bifid nose (also known as cleft nose, nasal cleft, or median nasal cleft) is a rare congenital malformation characterized by a partial or complete vertical splitting of the nose along the midline. This condition results from incomplete fusion of the nasal placodes during embryonic development, typically between the fourth and eighth weeks of gestation. The severity can range from a minor midline groove or notch at the nasal tip to a complete separation of the two nasal halves with widely spaced nostrils and a broad nasal bridge. In more severe forms, the underlying nasal cartilage and bone may also be cleft, and the condition may be associated with a widened nasal dorsum, hypertelorism (widely spaced eyes), or a midline dermoid cyst. Bifid nose can occur as an isolated anomaly or as part of broader syndromic conditions, including frontonasal dysplasia, Pai syndrome, or other midline developmental defects. When syndromic, additional features may include midline cleft lip, cranium bifidum occultum, intracranial lipomas, or other craniofacial anomalies. The body systems primarily affected are the craniofacial structures, particularly the nose and midface. Respiratory function may be impacted in severe cases due to structural abnormalities of the nasal passages. Treatment is primarily surgical and aims to reconstruct the nose for both functional and cosmetic purposes. Surgical repair typically involves rhinoplasty techniques to bring the separated nasal halves together, reconstruct the nasal framework, and achieve a more typical nasal appearance. The timing and complexity of surgery depend on the severity of the defect and whether associated anomalies are present. Multidisciplinary care involving craniofacial surgeons, otolaryngologists, and geneticists is often recommended, particularly in syndromic cases. Outcomes are generally favorable with appropriate surgical intervention, though multiple procedures may be needed as the child grows.
Clinical phenotype terms— hover any for plain English:
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Bifid nose.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Bifid nose at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Bifid nose.
Community
No community posts yet. Be the first to share your experience with Bifid nose.
Start the conversation →Latest news about Bifid nose
No recent news articles for Bifid nose.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Bifid nose
What is Bifid nose?
Bifid nose (also known as cleft nose, nasal cleft, or median nasal cleft) is a rare congenital malformation characterized by a partial or complete vertical splitting of the nose along the midline. This condition results from incomplete fusion of the nasal placodes during embryonic development, typically between the fourth and eighth weeks of gestation. The severity can range from a minor midline groove or notch at the nasal tip to a complete separation of the two nasal halves with widely spaced nostrils and a broad nasal bridge. In more severe forms, the underlying nasal cartilage and bone may
At what age does Bifid nose typically begin?
Typical onset of Bifid nose is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Bifid nose?
1 specialists and care centers treating Bifid nose are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.